203 related articles for article (PubMed ID: 18614367)
1. Exploring 9-benzyl purines as inhibitors of glutamate racemase (MurI) in Gram-positive bacteria.
Geng B; Breault G; Comita-Prevoir J; Petrichko R; Eyermann C; Lundqvist T; Doig P; Gorseth E; Noonan B
Bioorg Med Chem Lett; 2008 Aug; 18(15):4368-72. PubMed ID: 18614367
[TBL] [Abstract][Full Text] [Related]
2. Exploring 8-benzyl pteridine-6,7-diones as inhibitors of glutamate racemase (MurI) in gram-positive bacteria.
Breault GA; Comita-Prevoir J; Eyermann CJ; Geng B; Petrichko R; Doig P; Gorseth E; Noonan B
Bioorg Med Chem Lett; 2008 Dec; 18(23):6100-3. PubMed ID: 18947997
[TBL] [Abstract][Full Text] [Related]
3. Potent and selective inhibitors of Helicobacter pylori glutamate racemase (MurI): pyridodiazepine amines.
Geng B; Basarab G; Comita-Prevoir J; Gowravaram M; Hill P; Kiely A; Loch J; MacPherson L; Morningstar M; Mullen G; Osimboni E; Satz A; Eyermann C; Lundqvist T
Bioorg Med Chem Lett; 2009 Feb; 19(3):930-6. PubMed ID: 19097892
[TBL] [Abstract][Full Text] [Related]
4. Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.
Macielag MJ; Demers JP; Fraga-Spano SA; Hlasta DJ; Johnson SG; Kanojia RM; Russell RK; Sui Z; Weidner-Wells MA; Werblood H; Foleno BD; Goldschmidt RM; Loeloff MJ; Webb GC; Barrett JF
J Med Chem; 1998 Jul; 41(16):2939-45. PubMed ID: 9685233
[TBL] [Abstract][Full Text] [Related]
5. Bacterial translation inhibitors, 1-acylindazol-3-ols as anthranilic acid mimics.
Stiff C; Graber DR; Thorarensen A; Wakefield BD; Marotti KR; Melchior EP; Sweeney MT; Han F; Rohrer DC; Zurenko GE; Romero DL
Bioorg Med Chem Lett; 2008 Dec; 18(23):6293-7. PubMed ID: 18951783
[TBL] [Abstract][Full Text] [Related]
6. Pleuromutilin derivatives having a purine ring. Part 1: new compounds with promising antibacterial activity against resistant Gram-positive pathogens.
Hirokawa Y; Kinoshita H; Tanaka T; Nakamura T; Fujimoto K; Kashimoto S; Kojima T; Kato S
Bioorg Med Chem Lett; 2008 Jun; 18(12):3556-61. PubMed ID: 18511280
[TBL] [Abstract][Full Text] [Related]
7. Exiguaquinol: a novel pentacyclic hydroquinone from Neopetrosia exigua that inhibits Helicobacter pylori MurI.
de Almeida Leone P; Carroll AR; Towerzey L; King G; McArdle BM; Kern G; Fisher S; Hooper JN; Quinn RJ
Org Lett; 2008 Jun; 10(12):2585-8. PubMed ID: 18489104
[TBL] [Abstract][Full Text] [Related]
8. Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK.
Seefeld MA; Miller WH; Newlander KA; Burgess WJ; DeWolf WE; Elkins PA; Head MS; Jakas DR; Janson CA; Keller PM; Manley PJ; Moore TD; Payne DJ; Pearson S; Polizzi BJ; Qiu X; Rittenhouse SF; Uzinskas IN; Wallis NG; Huffman WF
J Med Chem; 2003 Apr; 46(9):1627-35. PubMed ID: 12699381
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design of a new series of D-glutamic acid based inhibitors of bacterial UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase (MurD).
Tomasić T; Zidar N; Sink R; Kovac A; Blanot D; Contreras-Martel C; Dessen A; Müller-Premru M; Zega A; Gobec S; Kikelj D; Masic LP
J Med Chem; 2011 Jul; 54(13):4600-10. PubMed ID: 21591605
[TBL] [Abstract][Full Text] [Related]
10. Exploitation of structural and regulatory diversity in glutamate racemases.
Lundqvist T; Fisher SL; Kern G; Folmer RH; Xue Y; Newton DT; Keating TA; Alm RA; de Jonge BL
Nature; 2007 Jun; 447(7146):817-22. PubMed ID: 17568739
[TBL] [Abstract][Full Text] [Related]
11. Novel and potent oxazolidinone antibacterials featuring 3-indolylglyoxamide substituents.
Takhi M; Singh G; Murugan C; Thaplyyal N; Maitra S; Bhaskarreddy KM; Amarnath PV; Mallik A; Harisudan T; Trivedi RK; Sreenivas K; Selvakumar N; Iqbal J
Bioorg Med Chem Lett; 2008 Sep; 18(18):5150-5. PubMed ID: 18768315
[TBL] [Abstract][Full Text] [Related]
12. Solid-phase synthesis of polyfunctionalized natural products: application to usnic acid, a bioactive lichen compound.
Tomasi S; Picard S; Lainé C; Babonneau V; Goujeon A; Boustie J; Uriac P
J Comb Chem; 2006; 8(1):11-4. PubMed ID: 16398547
[No Abstract] [Full Text] [Related]
13. Mechanistic analysis of muraymycin analogues: a guide to the design of MraY inhibitors.
Tanino T; Al-Dabbagh B; Mengin-Lecreulx D; Bouhss A; Oyama H; Ichikawa S; Matsuda A
J Med Chem; 2011 Dec; 54(24):8421-39. PubMed ID: 22085339
[TBL] [Abstract][Full Text] [Related]
14. Pleuromutilin derivatives having a purine ring. Part 3: synthesis and antibacterial activity of novel compounds possessing a piperazine ring spacer.
Hirokawa Y; Kinoshita H; Tanaka T; Nakamura T; Fujimoto K; Kashimoto S; Kojima T; Kato S
Bioorg Med Chem Lett; 2009 Jan; 19(1):175-9. PubMed ID: 19022668
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of pyrrolopyridine-substituted oxazolidinones: synthesis and in vitro SAR of various C-5 acetamide replacements.
Paget SD; Boggs CM; Foleno BD; Goldschmidt RM; Hlasta DJ; Weidner-Wells MA; Werblood HM; Bush K; Macielag MJ
Bioorg Med Chem Lett; 2006 Sep; 16(17):4537-42. PubMed ID: 16806921
[TBL] [Abstract][Full Text] [Related]
16. Design of Helicobacter pylori glutamate racemase inhibitors as selective antibacterial agents: a novel pro-drug approach to increase exposure.
Basarab GS; Hill PJ; Rastagar A; Webborn PJ
Bioorg Med Chem Lett; 2008 Aug; 18(16):4716-22. PubMed ID: 18640833
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial activity of nocathiacin I analogues.
Naidu BN; Sorenson ME; Matiskella JD; Li W; Sausker JB; Zhang Y; Connolly TP; Lam KS; Bronson JJ; Pucci MJ; Yang H; Ueda Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3545-9. PubMed ID: 16621551
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of caprazamycin analogues and their structure--activity relationship for antibacterial activity.
Hirano S; Ichikawa S; Matsuda A
J Org Chem; 2008 Jan; 73(2):569-77. PubMed ID: 18092805
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antibacterial activity of potent heterocyclic oxazolidinones and the identification of RBx 8700.
Rudra S; Yadav A; Raja Rao AV; Srinivas AS; Pandya M; Bhateja P; Mathur T; Malhotra S; Rattan A; Salman M; Mehta A; Cliffe IA; Das B
Bioorg Med Chem Lett; 2007 Dec; 17(24):6714-9. PubMed ID: 17980588
[TBL] [Abstract][Full Text] [Related]
20. Semisynthetic approaches to laspartomycin analogues.
Curran WV; Leese RA; Jarolmen H; Borders DB; Dugourd D; Chen Y; Cameron DR
J Nat Prod; 2007 Mar; 70(3):447-50. PubMed ID: 17323996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
